As of 2025-06-30, the Relative Valuation of Mersana Therapeutics Inc (MRSN) is (9.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 USD, the upside of Mersana Therapeutics Inc based on Relative Valuation is -3444.4%.
The range of the Relative Valuation is (8.06) - (11.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 22.8x | 19.0x |
| Forward P/E multiples | 16.6x - 27.1x | 21.8x |
| Fair Price | (8.06) - (11.04) | (9.90) |
| Upside | -2821.4% - -3831.3% | -3444.4% |
| Date | P/E |
| 2025-06-26 | -0.67 |
| 2025-06-25 | -0.72 |
| 2025-06-24 | -0.70 |
| 2025-06-23 | -0.70 |
| 2025-06-20 | -0.75 |
| 2025-06-18 | -0.73 |
| 2025-06-17 | -0.73 |
| 2025-06-16 | -0.78 |
| 2025-06-13 | -0.76 |
| 2025-06-12 | -0.75 |
| 2025-06-11 | -0.78 |
| 2025-06-10 | -0.84 |
| 2025-06-09 | -0.81 |
| 2025-06-06 | -0.80 |
| 2025-06-05 | -0.76 |
| 2025-06-04 | -0.76 |
| 2025-06-03 | -0.72 |
| 2025-06-02 | -0.77 |
| 2025-05-30 | -0.71 |
| 2025-05-29 | -0.72 |
| 2025-05-28 | -0.75 |
| 2025-05-27 | -0.74 |
| 2025-05-23 | -0.73 |
| 2025-05-22 | -0.80 |
| 2025-05-21 | -0.73 |
| 2025-05-20 | -0.80 |
| 2025-05-19 | -0.79 |
| 2025-05-16 | -0.70 |
| 2025-05-15 | -0.65 |
| 2025-05-14 | -0.78 |
| 2025-05-13 | -0.74 |
| 2025-05-12 | -0.74 |
| 2025-05-09 | -0.66 |
| 2025-05-08 | -0.69 |
| 2025-05-07 | -0.67 |
| 2025-05-06 | -0.65 |
| 2025-05-05 | -0.75 |
| 2025-05-02 | -0.82 |
| 2025-05-01 | -0.82 |
| 2025-04-30 | -0.89 |
| 2025-04-29 | -0.76 |
| 2025-04-28 | -0.79 |
| 2025-04-25 | -0.75 |
| 2025-04-24 | -0.75 |
| 2025-04-23 | -0.80 |
| 2025-04-22 | -0.77 |
| 2025-04-21 | -0.67 |
| 2025-04-17 | -0.73 |
| 2025-04-16 | -0.69 |
| 2025-04-15 | -0.72 |